Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
ZEPP Transcript
Zepp Health Corporation (ZEPP) Q3 2025 Earnings Call Transcript
Positive11-5
The earnings call summary indicates strong revenue growth, improved gross margins, and a solid cash position. Product launches and market expansion plans are promising. The Q&A reveals supply constraints but management is optimistic about resolving these issues and anticipates strong holiday demand. Conservative guidance and positive feedback on new products suggest potential growth. Despite some uncertainties, the overall sentiment is positive, likely resulting in a stock price increase.
Zepp Health Corporation (ZEPP) Q2 2025 Earnings Call Transcript
Positive8-4
The earnings call reveals a strong financial performance with a 46% YoY revenue increase and improved operating loss. Despite slight gross margin decline, management anticipates future expansion. The share repurchase program reflects confidence in long-term growth. Although there are concerns about management's vague responses, the product pipeline and strategic initiatives, like tariff mitigation, are promising. Given the positive Q3 guidance and shareholder value focus, the stock price is likely to rise 2-8%.
Zepp Health Corporation (NYSE:ZEPP) Q1 2025 Earnings Call Transcript
Unknown5-21
The earnings call highlights positive aspects such as year-over-year revenue growth, gross margin expansion, and a share repurchase program, which are offset by increased operating expenses and foreign exchange headwinds. The Q&A session revealed management's lack of clarity on product launches and full-year performance guidance, which introduces uncertainty. Despite a strong product reception, macroeconomic challenges and competitive pressures remain concerns. The combination of these factors suggests a neutral stock price movement over the next two weeks.
Zepp Health Corporation (ZEPP) Q1 2025 Earnings Call Transcript
Unknown5-20
The earnings call presented mixed signals. While there is optimism in revenue growth and gross margin expansion, geopolitical risks and increased tariffs pose challenges. The share repurchase program is positive, but increased operating expenses and adjusted operating losses are concerning. The Q&A revealed uncertainties regarding tariffs and product launches, further contributing to a neutral outlook.
ZEPP Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
